Product Images Gabapentin

This text appears to be a formula for estimating the renal clearance (cLcr) of a patient based on their age and weight (in kg) along with their serum creatinine level (in mg/dL). Specifically, the formula states that cLcr is equal to 140 minus the patient's age in years multiplied by their weight in kg, and then adjusted for female patients by dividing the result by 85. This value is then divided by their serum creatinine level in mg/dL, which is multiplied by 72. The purpose of this formula is to help healthcare providers assess a patient's kidney function, as renal clearance is a key measure of how well the kidneys are able to filter waste products from the blood.*

This is a prescription drug identified as Gabapentin 300mg enclosed in 100 capsules per bottle. It is manufactured by Actavis Elizabeth LLC in Elizabeth, NJ, USA. The capsules are yellow and light brown with the logo "2666" printed on both the cap and body of the capsule in black ink. The drug should be stored at a temperature of 20°C-25°C (68°77°F) and kept out of children's reach. Each capsule contains Gabapentin, USP 300 mg. It is necessary to provide patients with a separate medication guide. Lot #00000 Exp 0000000. NOC 63187-98800 P!.*

The text provides a summary of the mean pain score observed during a clinical study that had a dose titration period of 4 weeks followed by a fixed dose period of 4 weeks. The study tested the effects of Gabapentin at a daily dose of 3600mg compared to a Placebo. However, no further information or context is available, making it difficult to draw any conclusions or provide a more detailed description.*

This is a report on the mean pain score with different doses of Gabapentin during different periods of treatment. The dosage of Gabapentin was either 1800 mg/day or 2400 mg/day. The periods during which the doses were administered were a 4-week fixed dose period and a titration period. The report also mentions the lack of a placebo group. However, there is not enough information provided to give any further context or interpretation.*